DOXCYCLINE ANHYDROUS

DOXCYCLINE ANHYDROUS Brand names, DOXCYCLINE ANHYDROUS Analogs

DOXCYCLINE ANHYDROUS Brand Names Mixture

No information avaliable

DOXCYCLINE ANHYDROUS Chemical_Formula

C₂₂H₂₄N₂O₈

DOXCYCLINE ANHYDROUS RX_link

http://www.rxlist.com/cgi/generic/doxycyc.htm

DOXCYCLINE ANHYDROUS fda sheet

DOXCYCLINE_ANHYDROUS FDA

DOXCYCLINE ANHYDROUS msds (material safety sheet)

DOXCYCLINE_ANHYDROUS MSDS

DOXCYCLINE ANHYDROUS Synthesis Reference

C. R. Stephens et al.; J. Am. Chem. Soc. 80; 5324 (1958)

DOXCYCLINE ANHYDROUS Molecular Weight

444.435 g/mol

DOXCYCLINE ANHYDROUS Melting Point

201 ^oC

DOXCYCLINE ANHYDROUS H₂O Solubility

630 mg/L

DOXCYCLINE ANHYDROUS State

Solid

DOXCYCLINE ANHYDROUS LogP

-1.219

DOXCYCLINE ANHYDROUS Dosage Forms

Tablet; Capsule; Gel; Liquid; Powder; Powder for solution

DOXCYCLINE ANHYDROUS Indication

For the treatment of the following infections:Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae, Chancroid caused by Haemophilus ducreyi, Uncomplicated gonorrhea caused by Neisseria gonorrhoeae, Respiratory tract infections caused by Mycoplasma pneumoniae or Streptococcus pneumoniae. Lymphogranuloma ve

DOXCYCLINE ANHYDROUS Pharmacology

Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.

DOXCYCLINE ANHYDROUS Absorption

completely absorbed after oral administration

DOXCYCLINE ANHYDROUS side effects and Toxicity

anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region. skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD₅₀=262 mg/kg(i.p. in rat)

DOXCYCLINE ANHYDROUS Patient Information

DOXCYCLINE ANHYDROUS Organisms Affected

Enteric bacteria and other eubacteria